Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023

SELL
$40.29 - $82.51 $20,668 - $42,327
-513 Reduced 4.3%
11,414 $473,000
Q1 2023

Apr 17, 2023

SELL
$56.44 - $118.81 $20,205 - $42,533
-358 Reduced 2.91%
11,927 $717,000
Q4 2022

Jan 12, 2023

SELL
$63.98 - $85.37 $9,341 - $12,464
-146 Reduced 1.17%
12,285 $0
Q3 2022

Oct 18, 2022

SELL
$67.99 - $89.57 $45,893 - $60,459
-675 Reduced 5.15%
12,431 $945,000
Q2 2022

Jul 13, 2022

SELL
$56.6 - $89.9 $8,886 - $14,114
-157 Reduced 1.18%
13,106 $911,000
Q1 2022

May 10, 2022

SELL
$60.15 - $84.52 $17,984 - $25,271
-299 Reduced 2.2%
13,263 $1.1 Million
Q4 2021

Feb 08, 2022

BUY
$75.08 - $121.99 $1.02 Million - $1.65 Million
13,562 New
13,562 $1.02 Million

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $2.76B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Private Harbour Investment Management & Counsel, LLC Portfolio

Follow Private Harbour Investment Management & Counsel, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Harbour Investment Management & Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Harbour Investment Management & Counsel, LLC with notifications on news.